Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_provenance.
- NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_assertion description "[The impact of combined genotypes of the CYP1A1 Ile/Val polymorphism and GSTM1 on mutation of K-ras was also analyzed, and a higher risk of having a mutated K-ras gene was found for both the CYP1A1 Ile/Ile and GSTM1(-) (OR, 6.32; p=0.021; 95% CI, 1.33-30.19) and CYP1A1 Ile/Val and GSTM1(-) (OR, 6.09; p=0.042; 95% CI, 1.07-34.72) genotype combinations in patients with adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_provenance.
- NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_assertion evidence source_evidence_literature NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_provenance.
- NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_assertion SIO_000772 15375499 NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_provenance.
- NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_assertion wasDerivedFrom befree-20140225 NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_provenance.
- NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_assertion wasGeneratedBy ECO_0000203 NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP428538.RA8q5UA1S8GQPpc5Tfw2ixM81l1aiYZ8pBPI2ChNBHNXI130_provenance.